Respiratory syncytial virus
The importance of vaccines in cardiovascular prevention: an ESC clinical consensus statement
Serum IgA identified as reliable biomarker for infant RSV infection
Dramatic reduction in hospitalisation from RSV vaccination revealed
Single-injection nirsevimab to protect premature babies against RSV to be rolled out
Be alert to Guillain-Barré risk after RSV vaccination in older adults, says MHRA
Hospitalisation of older people drops due to RSV vaccination, study finds
World-first national RSV vaccination programme aims to reduce winter pressures on UK hospitals
RSV routine vaccination for babies and older adults in the UK recommended by JCVI
RSV infection during infancy increases subsequent asthma risk
Maternal vaccination effective against infant severe RSV infection
RSVpreF vaccine candidate effective against respiratory syncytial virus